While scientists have known for more than two decades that all cells use a strategy called RNA interference to regulate gene ...
As nucleic acid–based therapeutics evolve and mature, so too must the analytical tools that are designed to characterize them. New microfluidic capillary electrophoresis (CE) methods that are designed ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular ...
Hosted on MSN
RNA-based therapy reaches proof-of-concept for autism-related gene mutations in preclinical models
A single injection into the bloodstream of a mouse corrected a mutation linked to autism in neurons throughout the brain and reversed the animal’s social and behavioral deficits. That result, ...
Research for other indications is ongoing. In the first trial of microRNA inhibition to treat heart failure, a novel agent ...
An experimental RNA-based therapy shows promise for ALS by preventing TDP-43 protein clumping. An international team of scientists has developed an RNA-based experimental medicine that has the ...
Researchers at the International Institute of Molecular and Cell Biology in Warsaw (IIMCB), led by Prof. Gracjan Michlewski, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results